Cost-effectiveness of thrombolysis with recombinant tissue plasminogen activator for acute ischemic stroke assessed by a model based on UK NHS costs

Peter Sandercock, Eivind Berge, Martin Dennis, John Forbes, Peter Hand, Joseph Kwan, Steff Lewis, Richard Lindley, Aileen Neilson, Joanna Wardlaw

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Cost-effectiveness of thrombolysis with recombinant tissue plasminogen activator for acute ischemic stroke assessed by a model based on UK NHS costs'. Together they form a unique fingerprint.

Medicine & Life Sciences